Sionna Therapeutics, Inc. (NASDAQ:SION – Get Free Report)’s share price gapped up prior to trading on Monday . The stock had previously closed at $16.27, but opened at $16.60. Sionna Therapeutics shares last traded at $16.00, with a volume of 29,024 shares.
Wall Street Analyst Weigh In
A number of brokerages have recently commented on SION. TD Cowen assumed coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They set a “buy” rating for the company. Guggenheim assumed coverage on Sionna Therapeutics in a report on Tuesday, March 4th. They set a “buy” rating and a $45.00 price objective on the stock. Finally, Stifel Nicolaus began coverage on Sionna Therapeutics in a research note on Tuesday, March 4th. They issued a “buy” rating and a $32.00 price target on the stock.
Read Our Latest Stock Report on Sionna Therapeutics
Sionna Therapeutics Price Performance
About Sionna Therapeutics
We are a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (“CF”) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (“CFTR”) protein to deliver clinically meaningful benefit to CF patients.
Featured Articles
- Five stocks we like better than Sionna Therapeutics
- Stock Dividend Cuts Happen Are You Ready?
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- How to Short Nasdaq: An Easy-to-Follow Guide
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
- Comparing and Trading High PE Ratio Stocks
- Energy and Basic Materials Sectors Will Dominate in 2025
Receive News & Ratings for Sionna Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sionna Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
